Matches in SemOpenAlex for { <https://semopenalex.org/work/W2904751944> ?p ?o ?g. }
- W2904751944 endingPage "e88" @default.
- W2904751944 startingPage "e79" @default.
- W2904751944 abstract "The prevalence of deep venous thrombosis in patients with advanced cancer is unconfirmed and it is unknown whether current international thromboprophylaxis guidance is applicable to this population. We aimed to determine prevalence and predictors of femoral deep vein thrombosis in patients admitted to specialist palliative care units (SPCUs).We did this prospective longitudinal observational study in five SPCUs in England, Wales, and Northern Ireland (four hospices and one palliative care unit). Consecutive adults with cancer underwent bilateral femoral vein ultrasonography on admission and weekly until death or discharge for a maximum of 3 weeks. Data were collected on performance status, attributable symptoms, and variables known to be associated with venous thromboembolism. Patients with a short estimated prognosis (<5 days) were ineligible. The primary endpoint of the study was the prevalence of femoral deep vein thrombosis within 48 h of SPCU admission, analysed by intention to treat. This study is registered with the ISRCTN registry, number ISRCTN97567719.Between June 20, 2016, and Oct 16, 2017, 343 participants were enrolled (mean age 68·2 years [SD 12·8; range 25-102]; 179 [52%] male; mean Australian-modified Karnofsky performance status 49 [SD 16·6; range 20-90]). Of 273 patients with evaluable scans, 92 (34%, 95% CI 28-40) had femoral deep vein thrombosis. Four participants with a scan showing no deep vein thrombosis on admission developed a deep vein thrombosis on repeat scanning over 21 days. Previous venous thromboembolism (p=0·014), being bedbound in the past 12 weeks for any reason (p=0·003), and lower limb oedema (p=0·009) independently predicted deep vein thrombosis. Serum albumin concentration (p=0·43), thromboprophylaxis (p=0·17), and survival (p=0·45) were unrelated to deep vein thrombosis.About a third of patients with advanced cancer admitted to SPCUs had a femoral deep vein thrombosis. Deep vein thrombosis was not associated with thromboprophylaxis, survival, or symptoms other than leg oedema. These findings are consistent with venous thromboembolism being a manifestation of advanced disease rather than a cause of premature death. Thromboprophylaxis for SPCU inpatients with poor performance status seems to be of little benefit.National Institute for Health Research (Research for Patient Benefit programme)." @default.
- W2904751944 created "2018-12-22" @default.
- W2904751944 creator A5002637773 @default.
- W2904751944 creator A5009480543 @default.
- W2904751944 creator A5014854290 @default.
- W2904751944 creator A5019985889 @default.
- W2904751944 creator A5042730744 @default.
- W2904751944 creator A5062795370 @default.
- W2904751944 creator A5067391241 @default.
- W2904751944 creator A5070474680 @default.
- W2904751944 creator A5074740633 @default.
- W2904751944 creator A5075544315 @default.
- W2904751944 creator A5077612021 @default.
- W2904751944 date "2019-02-01" @default.
- W2904751944 modified "2023-10-16" @default.
- W2904751944 title "Prevalence, symptom burden, and natural history of deep vein thrombosis in people with advanced cancer in specialist palliative care units (HIDDen): a prospective longitudinal observational study" @default.
- W2904751944 cites W192935245 @default.
- W2904751944 cites W1964174069 @default.
- W2904751944 cites W1973509710 @default.
- W2904751944 cites W1979010119 @default.
- W2904751944 cites W1981072161 @default.
- W2904751944 cites W1990670070 @default.
- W2904751944 cites W2005750941 @default.
- W2904751944 cites W2006296021 @default.
- W2904751944 cites W2023784356 @default.
- W2904751944 cites W2042182191 @default.
- W2904751944 cites W2045858611 @default.
- W2904751944 cites W2082606443 @default.
- W2904751944 cites W2103055607 @default.
- W2904751944 cites W2111532639 @default.
- W2904751944 cites W2116728785 @default.
- W2904751944 cites W2122958857 @default.
- W2904751944 cites W2150121055 @default.
- W2904751944 cites W2162499932 @default.
- W2904751944 cites W2166087120 @default.
- W2904751944 cites W2167824121 @default.
- W2904751944 cites W2169423683 @default.
- W2904751944 cites W2196970594 @default.
- W2904751944 cites W2235535940 @default.
- W2904751944 cites W2259176485 @default.
- W2904751944 cites W2562925137 @default.
- W2904751944 cites W2883326945 @default.
- W2904751944 cites W4296148784 @default.
- W2904751944 doi "https://doi.org/10.1016/s2352-3026(18)30215-1" @default.
- W2904751944 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6352715" @default.
- W2904751944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30709436" @default.
- W2904751944 hasPublicationYear "2019" @default.
- W2904751944 type Work @default.
- W2904751944 sameAs 2904751944 @default.
- W2904751944 citedByCount "47" @default.
- W2904751944 countsByYear W29047519442019 @default.
- W2904751944 countsByYear W29047519442020 @default.
- W2904751944 countsByYear W29047519442021 @default.
- W2904751944 countsByYear W29047519442022 @default.
- W2904751944 countsByYear W29047519442023 @default.
- W2904751944 crossrefType "journal-article" @default.
- W2904751944 hasAuthorship W2904751944A5002637773 @default.
- W2904751944 hasAuthorship W2904751944A5009480543 @default.
- W2904751944 hasAuthorship W2904751944A5014854290 @default.
- W2904751944 hasAuthorship W2904751944A5019985889 @default.
- W2904751944 hasAuthorship W2904751944A5042730744 @default.
- W2904751944 hasAuthorship W2904751944A5062795370 @default.
- W2904751944 hasAuthorship W2904751944A5067391241 @default.
- W2904751944 hasAuthorship W2904751944A5070474680 @default.
- W2904751944 hasAuthorship W2904751944A5074740633 @default.
- W2904751944 hasAuthorship W2904751944A5075544315 @default.
- W2904751944 hasAuthorship W2904751944A5077612021 @default.
- W2904751944 hasBestOaLocation W29047519441 @default.
- W2904751944 hasConcept C121608353 @default.
- W2904751944 hasConcept C126322002 @default.
- W2904751944 hasConcept C141071460 @default.
- W2904751944 hasConcept C159110408 @default.
- W2904751944 hasConcept C168563851 @default.
- W2904751944 hasConcept C188816634 @default.
- W2904751944 hasConcept C203092338 @default.
- W2904751944 hasConcept C23131810 @default.
- W2904751944 hasConcept C2778959117 @default.
- W2904751944 hasConcept C2780011451 @default.
- W2904751944 hasConcept C2780868729 @default.
- W2904751944 hasConcept C2908647359 @default.
- W2904751944 hasConcept C2994186709 @default.
- W2904751944 hasConcept C71924100 @default.
- W2904751944 hasConcept C99454951 @default.
- W2904751944 hasConceptScore W2904751944C121608353 @default.
- W2904751944 hasConceptScore W2904751944C126322002 @default.
- W2904751944 hasConceptScore W2904751944C141071460 @default.
- W2904751944 hasConceptScore W2904751944C159110408 @default.
- W2904751944 hasConceptScore W2904751944C168563851 @default.
- W2904751944 hasConceptScore W2904751944C188816634 @default.
- W2904751944 hasConceptScore W2904751944C203092338 @default.
- W2904751944 hasConceptScore W2904751944C23131810 @default.
- W2904751944 hasConceptScore W2904751944C2778959117 @default.
- W2904751944 hasConceptScore W2904751944C2780011451 @default.
- W2904751944 hasConceptScore W2904751944C2780868729 @default.
- W2904751944 hasConceptScore W2904751944C2908647359 @default.
- W2904751944 hasConceptScore W2904751944C2994186709 @default.
- W2904751944 hasConceptScore W2904751944C71924100 @default.
- W2904751944 hasConceptScore W2904751944C99454951 @default.